The Regis Healthcare Ltd (ASX: REG) share price is in focus after the company delivered an 18% lift in revenue in its H1 FY26 result.
Image Source: Getty Images
What did Regis Healthcare report?
- Revenue from services grew 18% to $667.7 million.
- Underlying EBITDA increased 4% to $70.6 million.
- Underlying NPAT edged up 0.1% to $29.7 million, while statutory NPAT fell to $13.4 million due to one-off costs.
- Net operating cash flow jumped 40% to $291.7 million.
- Interim dividend of 9.0 cents per share (100% franked), payable 9 April 2026.
- Net cash position improved 10% to $198.0 million.
What else do investors need to know?
Regis reported mature homes average occupancy of 96.0%, with total occupied bed days rising 7%. The company benefited from increased government funding, improved room pricing, and recent acquisitions, which expanded its national portfolio by over 1,000 beds.
Several one-off expenses, including $12.8 million in acquisition and integration costs, impacted statutory profits. Capital expenditure reached $102.1 million, focused on acquisitions, property upgrades, and progressing greenfield developments at Toowong and Carlingford.
Staff levels increased to meet mandated care targets, while staff turnover dropped to 20.2%. The acquisitions of Rockpool and OC Health have been integrated and are expected to contribute positively in future periods.
What did Regis Healthcare management say?
Managing Director and CEO Dr Linda Mellors said:
Our half-year results demonstrate the resilience and momentum of the business as we continue to operate in a rapidly evolving operating environment. We remain focused on delivering high-quality care while advancing our growth strategy, supported by high occupancy and continued investment in our people and service offering. Revenue growth was driven by higher AN-ACC pricing, improved occupancy, and the recent acquisitions of Ti Tree Operations Pty Ltd (Ti Tree), Rockpool and OC Health, collectively adding eight homes and over 1,000 beds to our national portfolio. We also delivered an exceptional cashflow result, driven by increased net RAD cash inflows, reinforcing the strength of our market position.
What's next for Regis Healthcare?
Regis is targeting growth to 10,000 quality beds by FY28, through a mix of greenfield projects and acquisitions. An active development pipeline is expected to add 300–450 beds from new builds by FY28, with the remainder from M&A.
The company expects continued benefits from aged care funding reforms and demographic shifts. It is guiding to FY26 underlying EBITDA in the range of $130 million to $135 million as it executes its growth strategy, supported by a strong balance sheet.
Regis Healthcare share price snapshot
Over the past 12 months, Regis Healthcare shares have risen 1%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 9% over the same period.
